The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette's Disorder
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metoclopramide resulted in 39% tic reduction and is shown to be an effective treatment for tics.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [111]
In the citing paper
“Placebo resulted in 13% tic reduction.”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [111]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., Findling, R. L., & Risperidone Disruptive Behavior Study Group (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1337 · Cited by 475
A placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Research works printed but not linked: 29
- Acosta, 2004, Use of the “inverse neuroleptic” metoclopramide in Tourette syndrome: an open case series, J Child Adolesc Psychopharmacol, 14, 123, 10.1089/104454604773840562 · DOI
- Bruggeman, 2001, Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study, J Clin Psychiatry, 62, 50, 10.4088/JCP.v62n0111 · DOI · Paper page
- Campbell, 1985, Measurement of side effects, including tardive dyskinesia, Psychopharmacol Bull, 21, 1063
- Conners, 1985, Rating scales and checklists for child psychopharmacology, Psychopharmacol Bull, 21, 809
- Desai, 1983, Metoclopramide in Gilles de la Tourette's syndrome (a case report), J Postgrad Med, 29, 181
- Deutch, 1996, Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate, Synapse, 23, 182, 10.1002/(SICI)1098-2396(199607)23:3<182::AID-SYN7>3.0.CO;2-4 · doi:10.1002/(sici)1098-2396(199607)23:3<182::aid-syn7>3.0.co;2-4
- Gagliano, 2004, Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications, J Child Adolesc Psychopharmacol, 14, 39, 10.1089/104454604773840472 · DOI
- Ganzini, 1993, The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders, Arch Intern Med, 153, 1469, 10.1001/archinte.1993.00410120051007 · doi:10.1001/archinte.1993.00410120051007 · Paper page
- Gilbert, 2004, Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial, J Am Acad Child Adolesc Psychiatry, 43, 206, 10.1097/00004583-200402000-00017 · DOI
- Goodman, 1989, The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability, Arch Gen Psychiatry, 46, 1006, 10.1001/archpsyc.1989.01810110048007 · DOI · Paper page
- Hasan, 2003, Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl, Eur J Pharm Biopharm, 55, 339, 10.1016/S0939-6411(03)00022-5 · doi:10.1016/s0939-6411(03)00022-5
- Hiroi, 1996, Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum, J Comp Neurol, 374, 70, 10.1002/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K · DOI
- Jankovic, 2001, Tourette's syndrome, N Engl J Med, 345, 1184, 10.1056/NEJMra010032 · DOI · Paper page
- Kaufman, 1997, Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data, J Am Acad Child Adolesc Psychiatry, 36, 980, 10.1097/00004583-199707000-00021 · DOI · Paper page
- Leckman, 2002, Tourette's syndrome, Lancet, 360, 1577, 10.1016/S0140-6736(02)11526-1 · DOI · Paper page
- Leckman, 1989, The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
- Margolese, 2002, Depression and dysphoria in adult and adolescent patients with Tourette's disorder treated with risperidone, J Clin Psychiatry, 63, 1040, 10.4088/JCP.v63n1115 · DOI
- Pinder, 1976, Metoclopramide: a review of its pharmacological properties and clinical use, Drugs, 12, 81, 10.2165/00003495-197612020-00001 · DOI · Paper page
- Robertson, 1994, Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity, J Pharmacol Exp Ther, 271, 1058
- Robertson, 2003, Diagnosing Tourette syndrome: is it a common disorder?, J Psychosom Res, 55, 3, 10.1016/S0022-3999(02)00580-9 · DOI
- Sallee, 2000, Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study, J Am Acad Child Adolesc Psychiatry, 39, 292, 10.1097/00004583-200003000-00010 · DOI · Paper page
- Sandor, 2003, Pharmacological management of tics in patients with TS, J Psychosom Res, 55, 41, 10.1016/S0022-3999(03)00060-6 · DOI
- Shapiro, 1989, Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
- Simpson, 1970, A rating scale for extrapyramidal side effects, Acta Psychiatr Scand Suppl, 212, 11, 10.1111/j.1600-0447.1970.tb02066.x · DOI · Paper page
- Singer, 2001, Neurochemistry and synaptic transmission in Tourette syndrome, Adv Neurol, 85, 163
- Smirnov, 1989, Use of metoclopramide (Cerucal) in Tourette syndrome, Zh Nevropatol Psikhiatr Im S S Korsakova, 89, 105
- Stanley, 1980, Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models, Psychopharmacology (Berl), 71, 219, 10.1007/BF00433055 · DOI
- Voruganti, 2004, Neuroleptic dysphoria: towards a new synthesis, Psychopharmacology (Berl), 171, 121, 10.1007/s00213-003-1648-y · DOI
- Wudarsky, 1999, Elevated prolactin in pediatric patients on typical and atypical antipsychotics, J Child Adolesc Psychopharmacol, 9, 239, 10.1089/cap.1999.9.239 · DOI
Cited by
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Treatment strategies for tics in Tourette syndrome
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285610390261 · Cited by 158
Metadata
- Authors
- Nicolson, R., Craven-Thuss, B., Smith, J., Mckinlay, B. D., & Castellanos, F. X.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 44
- Issue
- 7
- Pages
- 640-646
- ISSN
- 0890-8567
- Cited by
- 58
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette's Disorder. https://app.cochat.ai/papers/10.1097/01.chi.0000163279.39598.44
- The paper
- Nicolson, R., Craven-Thuss, B., Smith, J., Mckinlay, B. D., & Castellanos, F. X. (2005). A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette's Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/01.chi.0000163279.39598.44
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.